Insulin lispro

Details

Generic Name:
Insulin lispro
Project Status:
Cancelled
Manufacturer:
sanofi-aventis Canada Inc.
Call for patient/clinician input open:
Brand Name:
Admelog
Project Line:
Reimbursement Review
Project Number:
SE0543-000
Call for patient/clinician input closed:
Biosimilar:
Yes
Submission Type:
New
Fee Schedule:
Pending
Indications:
Diabetes mellitus, Type 1 & 2